Authors
Loading...
Preclinical study demonstrates that Cadherin-11 drives type II alveolar epithelial cell injury during pulmonary fibrosis, indicating a potential target for therapeutic intervention.
Pedroza et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: